Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 25uCi/ML | 0 | FERROUS CITRATE FE 59 | FERROUS CITRATE, FE-59 |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1973-12-17 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1977-07-27 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 1977-08-23 | PRIORITY |
LABELING; Labeling | SUPPL | 6 | AP | 2007-12-07 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 1982-05-10 | PRIORITY |
LABELING; Labeling | SUPPL | 9 | AP | 1984-05-24 | |
Submissions Property Types
SUPPL | 3 | Null | 0 |
SUPPL | 4 | Null | 0 |
SUPPL | 7 | Null | 0 |
CDER Filings
MALLINCKRODT
cder:Array
(
[0] => Array
(
[ApplNo] => 16729
[companyName] => MALLINCKRODT
[docInserts] => ["",""]
[products] => [{"drugName":"FERROUS CITRATE FE 59","activeIngredients":"FERROUS CITRATE, FE-59","strength":"25uCi\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"FERROUS CITRATE FE 59","submission":"FERROUS CITRATE, FE-59","actionType":"25uCi\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)